Octopus Investments Files Disclosure on Advanced Medical Solutions

Octopus Investments has filed a Form 8.3 disclosure in connection with Advanced Medical Solutions Group plc, according to a regulatory notice distributed through GlobalNewswire. The filing represents a standard transparency requirement under United Kingdom takeover rules when an investor holds or acquires a material interest in a company that is subject to an offer period.

Form 8.3 filings are mandated by the UK Takeover Panel and must be submitted by any person who holds, directly or indirectly, one percent or more of any class of relevant securities in an offeree or offeror company during an active offer period. The disclosures are designed to provide market participants and regulators with a clear picture of significant ownership positions as deal activity unfolds.

Read more Coinbase Wins CFTC Approval to Operate US Derivatives Clearinghouse →

Advanced Medical Solutions Group plc is a UK-based developer and manufacturer of advanced wound care and wound closure products, serving healthcare markets across Europe and beyond. The company's securities have been subject to increased investor scrutiny in connection with the circumstances that triggered the offer-period designation.

Octopus Investments, a London-headquartered asset management firm known for its positions in smaller UK-listed companies, is among the institutional investors required to publicly disclose movements in such holdings. The submission of this form does not by itself indicate a change in strategy or a new transaction, but it does place the firm's position on the public record as required by law.

Full details of the specific securities, positions, and any dealings disclosed in the filing are available in the original document. Continue reading at GlobalNewswire.